Inspire Medical Systems Cash Flow from Operating Activities 2017-2024 | INSP
Inspire Medical Systems cash flow from operating activities from 2017 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Inspire Medical Systems Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $130 |
| 2023 | $25 |
| 2022 | $12 |
| 2021 | $-20 |
| 2020 | $-53 |
| 2019 | $-33 |
| 2018 | $-19 |
| 2017 | $-16 |
| 2016 | $-18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.740B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.685B | 52.05 |
| Tempus AI (TEM) | United States | $8.308B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.565B | 105.54 |
| IRhythm Technologies (IRTC) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.706B | 204.09 |
| Enovis (ENOV) | United States | $2.177B | 13.50 |
| Clover Health Investments (CLOV) | United States | $1.834B | 0.00 |
| Omnicell (OMCL) | United States | $1.635B | 35.31 |
| Azenta (AZTA) | United States | $1.583B | 73.70 |
| Phreesia (PHR) | United States | $1.502B | 0.00 |
| Schrodinger (SDGR) | United States | $1.442B | 0.00 |
| 10x Genomics (TXG) | United States | $1.068B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.554B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.522B | 0.00 |
| Veradigm (MDRX) | United States | $0.469B | 0.00 |
| Talkspace (TALK) | United States | $0.431B | 256.00 |
| TruBridge (TBRG) | United States | $0.411B | 0.00 |
| Standard BioTools (LAB) | United States | $0.409B | 0.00 |
| Claritev (CTEV) | United States | $0.334B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.238B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.221B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| CareCloud (CCLD) | United States | $0.059B | 2.53 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |